J. Atzrodt et al. / Bioorg. Med. Chem. 20 (2012) 5658–5667
5667
4. (a) Guengerich, K. P. FASEB 1992, 6, 745; (b) Ayrton, J.; Plumb, R.; Leavens, W. J.;
Mallett, D.; Dickins, M.; Dear, G. J. Rapid Commun. Mass. Spectrom. 1998, 12,
217; (c) Zambon, S.; Fontana, S.; Kajbaf, M. Drug Metab. Lett. 2010, 4, 120.
5. Foti, R. S.; Rock, D. A.; Wienkers, L. C.; Wahlstrom, J. L. Drug Metab. Dispos. 2010,
38, 981.
6. Walsky, R. L.; Obach, R. S. Drug Metab. Dispos. 2004, 32, 647.
7. (a) Joubert, C.; Beney, C.; Marsura, A.; Luu-Duc, C. J. Labelled Compd.
Radiopharm. 1995, 36, 745; (b) Toft, P.; Liston, A. J.; Viau, A. Y. J. Labelled
Compd. Radiopharm. 1973, 9, 413.
17. (a) Ihara, M.; Tokunaga, Y.; Taniguchi, N.; Fukumoto, K. Tetrahedron 1991, 47,
6635; (b) Ihara, M.; Sudow, I.; Fukumoto, K. J. Chem. Soc., Perkin. Trans. 1 1986,
117. and references sited therein; (c) Kockert, K.; Vierhapper, F. W. Tetrahedron
2000, 56, 9967.
18. (a) Bowers, S.; Bowers, L. D. J. Steroid Biochem. Mol. Biol. 1996, 58, 225; (b)
Gaskell, S. J.; Finlay, E. M. H. J. Labelled Comp. Radiopharm. 1979, 6, 861.
19. (a) Wähälä, K.; Väänänen, T.; Hase, T.; Leinonen, A. J. Labelled Comp.
Radiopharm. 1995, 36, 493; (b) Krauser, J. A.; Guengerich, F. P. J. Biol. Chem.
2005, 280, 19496.
8. (a) Leroy, D.; Richard, J.; Goodbillon, J. J. Labelled Compd. Radiopharm. 1993, 33,
1019; (b) Leis, H. J.; Fauler, G.; Gleispach, H.; Windschofer, H. Rapid Commun.
Mass. Spectrom. 1996, 10, 1605; (c) Wu, K.; Tian, L.; Li, H.; Li, J.; Chen, L. J.
Labelled Compd. Radiopharm. 2009, 52, 535; (d) Moser, P.; Sallman, A.;
Wieseberg, I. J. Med. Chem. 1990, 33, 2358.
9. Zhang, Y.; Woo, P. W. K.; Hartman, J.; Colbry, N.; Huang, Y.; Huang, C. C.
Tetrahedron Lett. 2005, 46, 2087.
10. Heinkele, G.; Schänzle, G.; Mürdter, T. E. J. Labelled Compd. Radiopharm. 2002,
45, 1153.
20. (a) Derdau, V.; Atzrodt, J. Synlett 2006, 12, 1918; (b) Derdau, V.; Atzrodt, J.;
Holla, W. J. Labelled Compd. Radiopharm. 2007, 50, 295.
21. Cacchi, S.; La Torr, F.; Paolucci, G. Synthesis 1978, 848.
22. Gardi, R.; Lusignan, A. J. Org. Chem. 1967, 32, 2647.
23. Several other oxidations at the C6-position of steroids have been published, but
most of them suffering from low yield, bad conversion or the formation of a
broad range by-products (a) Dusza, J. P.; Joseph, J. P.; Bernstein, S. J. Org. Chem.
1962, 27, 4046; (b) Strommer, R.; Hoedl, C.; Strauss, W.; Sailer, R.; Haslinger, E.;
Schramm, H. W.; Seger, C. Monatshefte für Chemie 2004, 135, 1137; (c) Eppstein,
S. H.; Meister, P. D.; Leigh, H. M.; Peterson, D. H.; Murray, H. C.; Reineke, L. M.;
Weintraub, A. J. Am. Chem. Soc. 1954, 76, 3174; (d) Eriksson, C. G.; Eneroth, P.;
Nordstrom, L. J. Steroid Biochem. 1985, 22, 649; (e) Smith, K. E.; Latie, S.; Kirk, D.
N. J. Steroid Biochem. 1989, 32, 445; (f) Herzog, H. L.; Gentles, M. J.; Basch, A.;
Coscarelli, W.; Zeitz, M. E. A.; Charney, W. J. Org. Chem. 1960, 25, 2177.
24. (a) Obach, R. S.; Zhang, Q.-Y.; Dunbar, D.; Kaminsky, L. S. Drug Metab. Dispos.
2001, 29, 347; (b) Crepi, C. L.; Chang, T. K. H.; Waxman, D. J. Methods in
Molecular Biology In Cytochrome P450 Protocols; Phillips, I. R., Sheppard, E. A.,
Eds.; Humana Press Inc.: Tatowa NJ, 1998; Vol. 107, pp 129–134.
25. Zöllner, A.; Buchheit, D.; Mayer, M. R.; Maurer, H. H.; Peters, F. T.; Bureik, M.
Bioanalysis 2010, 2, 1277.
11. Furuta, T.; Suzuki, A.; Matsuzawa, M.; Shibasaki, H.; Kasuya, Y. Steroids 2003,
68, 693.
12. Waterhouse, I. J. Labelled Compd. Radiopharm. 1999, 42, 1075.
13. For recent reviews on H/D exchange, see: (a) Atzrodt, J.; Derdau, V.; Fey, T.;
Zimmermann, J. Angew. Chem. 2007, 119, 7890. Angew. Chem., Int. Ed. 2007, 46,
7744; (b) Lockley, W. J. S.; Heys, J. R. J. Labelled Compd. Radiopharm. 2010, 53,
635; (c) Lockley, W. J. S.; Hesk, D. J. Labelled Compd. Radiopharm. 2010, 53, 704;
(d) Atzrodt, J.; Derdau, V. J. Labelled Compd. Radiopharm. 2010, 53, 674.
14. 14 For recent publications on this topic, see: DCl: Martins, A.; Lautens, M. Org.
Lett. 2008, 10, 4351; Rh: Maegawa, T.; Fujiwara, Y.; Inagaki, Y.; Esaki, H.;
Monguchi, Y.; Sajiki, H. Angew. Chem. 2008, 120, 5474; Angew. Chem., Int. Ed.
2008, 47, 5394; Pd: (a) Esaki, H.; Ito, N.; Sakai, S.; Maegawa, T.; Monguchi, Y.;
Sajiki, H. Tetrahedron 2006, 62, 10954; (b) Kerler, B.; Pol, J.; Hartonen, K.;
Soederstroem, M.T.; Koskela, H.T.; Riekkola, M.-L. J. Supercrit. Fluids 2007, 39,
381; Ir: (a) Heys, J.R. J. Labelled Compd. Radiopharm. 2007, 50, 770; (b) Zhou, J.;
Hartwig, J. F. Angew. Chem. 2008, 120, 5867; Angew. Chem., Int. Ed. 2008, 47,
5783; (c) Träff, A.; Nilsson, G. N.; Szabo, K. J.; Eriksson, L. J. Organomet. Chem.
2007, 692, 5529-5531; (d) Brown, J. A.; Irvine, S.; Kennedy, A. R.; Kerr, W. J.;
Andersson, S.; Nilsson G. N. Chem. Commun. 2008, 1115; (e) Nilsson, G. N.; Kerr,
W. J. J. Labelled Compd. Radiopharm. 2010, 53, 662; Ru: (a) Prechtl, M. H. G.;
Hoelscher, M.; Ben-David, Y.; Theyssen, N.; Loschen, R.; Milstein, D.; Leitner, W.
Angew. Chem. 2007, 119, 2319; Angew. Chem. Int. Ed. 2007, 46, 2269; (b)
Ishibashi, K.; Matsubara, S. Chem. Lett. 2007, 36, 724.
26. Webster, R.; Pacey, M.; Winchester, T.; Johnson, P.; Jezequel, S. Appl. Microbiol.
Biotechnol. 1998, 49, 371.
27. Blake, M. I.; Crespi, H. L.; Katz, J. J. J. Pharm. Sci. 1975, 64, 367.
28. (a) Malmlöf, T.; Rylander, D.; Alken, R. G.; Schneider, F.; Svensson, T. H.; Cenci,
M. A.; Schilström, B. Exp. Neurol. 2010, 225, 408; (b) Shao, L.; Hewitt, M. C. Drug
News Perspect. 2010, 23, 398; (c) Sanderson, K. Nat. News 2009; (d) Buteau, K. C.
J. High Techol. Law 2009, 22, 23.
29. Walser, A.; Benjamin, L. E.; Flynn, T.; Mason, C.; Schwartz, R.; Fryer, R. I. J. Org.
Chem. 1978, 43, 936.
30. del Pozo, C.; Macias, A.; Alonso, E.; Gonzalez, J. Synthesis 2004, 16, 2697.
31. Jian, Z.; Wu, A.; Lin, M.; Jones, L.; Ray, T. J. Labelled Compd. Radiopharm. 2010,
53, 265.
15. At Sanofi, specifications for stable labelled internal standards include a narrow
isotope cluster, a D0 content of less than 0.5% and the presence of an abundant
representative mass peak, which can be used as the reference mass of the
internal standard; please see also: Derdau, V.; Kroll, C.; Brückner, F.; Atzrodt, J.
Chem. Eur. J. 2009, 15, 10397.
32. Allen, J.; Brasseur, D. M.; de Bruin, B.; Denoux, M.; Perard, S.; Philippe, N.; Roy,
S. J. Labelled Compd. Radiopharm. 2007, 50, 342.
33. Dragan, C.-A.; Peters, F. T.; Bour, P.; Schwaninger, A. E.; Schaan, S. M.; Neunzig,
I.; Widjaja, M.; Zapp, J.; Kraemer, T.; Maurer, H. H.; Bureik, M. Appl. Biochem.
Biotechnol. 2011, 163, 965.
16. (a) Fayer, J. L.; Petullo, D. M.; Ring, B. J.; Wrighton, S. A.; Ruterbories, K. J. J.
Pharmacol. Toxicol. Methods 2001, 46(2), 117; (b) Guengerich, F. P.; Martin, M.
V.; Beaume, P. H.; Kremers, P.; Wolff, T.; Waxman, D. J. J. Biol. Chem. 1986, 261,
5051.
34. Marvalin, C.; Denoux, M.; Perard, S.; Roy, S.; Azerad, R. Xenobiotica 2012, 42,
285.
35. (a) Garnett, J. L.; Hodges, R. J. J. Chem. Soc., Chem. Commun. 1967, 1001; (b)
Garnett, J. L.; Hodges, R. J. J. Am. Chem. Soc. 1967, 89, 4546.